Who is sponsoring NCT03791268?

NCT03791268 is sponsored by West China Hospital.

What drugs are being tested in NCT03791268?

Interventions in NCT03791268: Gastric cancer surgery.

What condition does NCT03791268 study?

NCT03791268 studies Stomach Adenocarcinoma.

Is NCT03791268 still recruiting?

NCT03791268 is currently status unknown. Last updated 2 January 2019.

Last reviewed 2019-01-02 · How we verify

NCT03791268

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

General Tissue Response Classification System After Chemotherapy

Status unknown Last updated 2 January 2019

What this trial tests

trial testing Gastric cancer surgery in Stomach Adenocarcinoma in 200 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	West China Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 January 2019
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across China

Drugs / interventions tested

Gastric cancer surgery

Conditions studied

Stomach Adenocarcinoma — all drugs for Stomach Adenocarcinoma →

Sponsor

West China Hospital

Who can join

Adults 18 to 75, any sex, with Stomach Adenocarcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research intend to collect the information of gastric cancer patients who received preoperative neoadjuvant chemotherapy and radical gastric ectomy at Department of Gastrointestinal Surgery, West China Hospital, Sichuan University. Base on The degree of edema, intraoperative effusion, fibrosis of connecting tissues, the investigators aim to constitute the core parameters of the tissue response grading system following neoadjuvant chemotherapy, and explore the mutual effect among the tissue response grading system, tumor regression response and long-term survival outcome of tumor patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study.
Yang H, Zhang WH, Ge R, Peng BQ, et al · · 2021 · cited 5× · PMID 34900661 · DOI 10.3389/fonc.2021.585006

Verify or expand the search:

Other trials of Gastric cancer surgery

Trials testing the same drug.

NCT04797624 — Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients? · completed

Other recruiting trials for Stomach Adenocarcinoma

Currently open trials in the same condition.

NCT06362070 — Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy · NA · recruiting
NCT04802876 — Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · Phase 2 · active not recruiting

Other West China Hospital trials

Trials by the same sponsor.

NCT07583654 — Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
NCT07583914 — Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
NCT07492914 — Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
NCT07507097 — Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke · NA · not yet recruiting
NCT07472933 — Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03791268 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by West China Hospital
Last refreshed: 2 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03791268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing